Page last updated: 2024-08-23

zingerone and Diabetic Nephropathies

zingerone has been researched along with Diabetic Nephropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, Y; Cui, Y; Hua, Q; Liu, Y; Shi, Y; Wang, S1
Ahmad, B; Ahmad, SB; Bhat, SA; Ganaie, MA; Madkhali, H; Majid, S; Rashid, SM; Rasool, S; Rehman, MU; Shakeel, S1

Other Studies

2 other study(ies) available for zingerone and Diabetic Nephropathies

ArticleYear
Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 99

    Topics: Animals; Cell Death; Collagen Type IV; Diabetic Nephropathies; Down-Regulation; Fibronectins; Glucose; Guaiacol; Humans; Inflammation; Kidney Tubules, Proximal; Lipids; Mice, Inbred C57BL; NADPH Oxidase 4; Oxidative Stress; Protective Agents; Up-Regulation

2018
Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy.
    Archives of physiology and biochemistry, 2019, Volume: 125, Issue:3

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Gene Expression Regulation; Guaiacol; Inflammation; Kidney Function Tests; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Respiratory Burst; Signal Transduction; Tumor Necrosis Factor-alpha

2019